• About
    • About Unique Finance
    • Directors Information
    • Global Presence
    • Our Core Values
  • Analysis
    • NASDAQ
    • Stock Market Analysis
  • Market Data
    • Advisory
    • Annual Report
    • Fashion
    • Food
    • Health
    • Initial Public Offerings
    • Lifestyle
    • Market Research Reports
    • Politics
    • Sports
    • Travel
  • Articles
    • Financial Sector and Stocks Analysis
    • IPO Analysis
    • Wall Street Breakfast
    • ETFs & Portfolio Strategy
  • News
    • Public Companies
    • Dividend Reports And Estimates
    • Earnings Releases And Operating Results
    • Mergers And Acquisitions
  • Trainings
    • Stock Trading Podcasts
    • Training Courses
    • The Stock Market – Spring 2017
    • NASDAQ Live
  • About
    • About Unique Finance
    • Directors Information
    • Global Presence
    • Our Core Values
  • Analysis
    • NASDAQ
    • Stock Market Analysis
  • Market Data
    • Advisory
    • Annual Report
    • Fashion
    • Food
    • Health
    • Initial Public Offerings
    • Lifestyle
    • Market Research Reports
    • Politics
    • Sports
    • Travel
  • Articles
    • Financial Sector and Stocks Analysis
    • IPO Analysis
    • Wall Street Breakfast
    • ETFs & Portfolio Strategy
  • News
    • Public Companies
    • Dividend Reports And Estimates
    • Earnings Releases And Operating Results
    • Mergers And Acquisitions
  • Trainings
    • Stock Trading Podcasts
    • Training Courses
    • The Stock Market – Spring 2017
    • NASDAQ Live

Point of Care Molecular Diagnostics Market revenue to cross USD 2.8 Bn by 2026: Global Market Insights, Inc.

Point of Care Molecular Diagnostics Market revenue to cross USD 2.8 Bn by 2026: Global Market Insights, Inc.

/
Date21 Sep 2020
/
CategoriesMarket Research Reports

Email

Print Friendly

Share


Selbyville, Delaware, Sept. 21, 2020 (GLOBE NEWSWIRE) —

According to latest report “PoC Molecular Diagnostics Market by Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), End-use (Hospitals, Clinics), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026”, by Global Market Insights, Inc., the market valuation of point of care (PoC) molecular diagnostics will cross $2.8 billion by 2026. Strategic initiatives for developing innovative PoC molecular diagnostics assays and instruments will accelerate the market growth.

Point of care molecular diagnostics tests deliver several benefits from enhancing patient care to limiting healthcare expenditure. High-quality diagnostic tests are widely available in developed countries, while developing economies face a shortage of high-quality diagnostic tools. Therefore, there is a rise in R&D investment by public and private organizations for delivering cost-effective and high-quality diagnostic tools to satisfy the growing consumer demand in developing countries of the Asia Pacific and Latin America.

Request for a sample of this research report @

https://www.gminsights.com/request-sample/detail/2210

The situ hybridization segment held over 20% of point of care molecular diagnostics market share in 2019. Rising utilization of in-situ hybridization in laboratories as well as research activities to diagnose infectious diseases, chromosomal abnormalities and cancer will contribute towards segment progression. Comparative genomic hybridization (CGH) and fluorescence in-situ hybridization (FISH) are effective techniques in detecting numerous genetic variations including aneuploidy, congenital abnormalities, and deletions.

The infectious disease application segment valuation was more than USD 780 million in 2019 due to increasing incidence of flu across the globe. For instance, according to CDC estimates, in the U.S. around 490,561 individuals were hospitalized and over 16 million people suffering from flu visited hospitals in the year 2018-2019. Moreover, rising laboratory capacity for the diagnosis of influenza among elderly population base, newborn babies and individual with certain chronic illnesses will further fuel the industry growth.

The hospital segment in the point of care molecular diagnostics market will showcase growth of around 8%till 2026 led by surging adoption of advanced technologies including PCR, isothermal amplification and sequencing among others in hospital settings for easy disease diagnosis. Additionally, various advantages such as improved treatment options with affordable treatment price will boost the overall market value.

Asia Pacific PoC molecular diagnostics market revenue exceeded USD 335 mn in 2019 on account of the favorable government initiatives for the early treatment and diagnosis of infectious diseases in Japan. For instance, introduction of Japan Nosocomial Infections Surveillance (JANIS) Program by Ministry of Health, Labor and Welfare. This program aims at providing information on prevalence and incidence of antimicrobial-resistant bacteria and infections in medical settings escalating the market size. Furthermore, well-established players such as Sysmex Corporation and others focus on developing novel products accelerating business expansion.

Request for customization of this research report @

https://www.gminsights.com/roc/2210

Some of the companies functioning in point of care (PoC) molecular diagnostics market include Bio-Rad Laboratories, Abbott Laboratories, Sysmex, Danaher, Vircell and others. These market leaders are focusing on developing innovative products that helps the company rise its market share globally. For instance, in December 2019, Roche acquired Spark Therapeutics, Inc. This strategy assisted the company expand its existing capabilities in the industry.

Table of Contents (ToC) of the report:

Chapter 3. PoC Molecular Diagnostics Market Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 – 2026

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.2.  Industry pitfalls and challenges

3.4. Growth potential analysis

3.4.1.  By technology

3.4.2.  By application

3.4.3.  By end-use

3.5. COVID-19 impact analysis

3.6. Technology landscape

3.7. All in one diagnostics solutions overview

3.8. Porter’s analysis

3.9. Competitive landscape, 2019

3.10.  PESTEL Analysis

Browse Complete Table of Contents (ToC) @

https://www.gminsights.com/toc/detail/point-of-care-poc-molecular-diagnostics-market

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]ts.com

 


Share Post: digg-share facebook-share google-share linked-share my-space-share pinterest-share reddit-share stumble-upon-share twitter-share
Global Water Soluble Polymers Industry

Stock Updates

  • Loading stock data...

Categories

  • Advisory
  • Annual Report
  • Dividend Reports And Estimates
  • Earnings Releases And Operating Results
  • ETFs & Portfolio Strategy
  • Financial Sector and Stocks Analysis
  • Health
  • Initial Public Offerings
  • IPO Analysis
  • Market Research Reports
  • Mergers And Acquisitions
  • NASDAQ
  • Public Companies
  • Stock Market Analysis
  • Stock Trading Podcasts
  • Wall Street Breakfast

Unique Finance is next generation of the same old businessmen and women who led the financial market in 20th century. We inherited their legacy and will lead the 21st century with confidence.

Associates Portal

All responsibilities of the Associates Portal segment of the company is under their respective representatives.

  • Portal MPGM-EC Suspended
  • Articles
  • Market Data
  • NASDAQ
  • News
  • Stock Market Analysis
  • Partners Portal
© 2022 Unique Finance. All Rights Reserved.      Home | Contact | Partners Portal
Risk Warning: Forward Rate Agreements, Options and CFDs (OTC Trading) are leveraged products that carry a substantial risk of loss up to your invested capital and may not be suitable for everyone. Please ensure that you fully understand the risks involved and do not invest money you cannot afford to lose.
© 2022